NDA Submitted for MDMA-Assisted Therapy for Posttraumatic Stress Disorder
MAPS has submitted an NDA for MDMA-assisted therapy for patients with posttraumatic stress disorder.
Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MAPS has submitted an NDA for MDMA-assisted therapy for patients with posttraumatic stress disorder.
Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.
RADNOR, Pa., Dec. 11, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced the Company will be participating in-person at the LifeSci...
New data on Auvelity’s impact on quality of life, measured by the Q-LES-Q-SF, in patients who had received at least one prior treatment during their current depressive episode
These stocks could be just the ticket for investors seeking strong growth.